KITLG and neoplasm: Given the characteristics of the substrates of SCF-cyclin F, the latter might be expected to act as a tumor suppressor, and most experimental studies have recently supported this thesis; however, those supporting its pro-tumorigenic activity also exist [12,20,21,22].